Table 3.
Fazekas | Reviewer 1 | Reviewer 2 | ||||
---|---|---|---|---|---|---|
Grade 0 | Grade 1 | Grade 2 | Grade 0 | Grade 1 | Grade 2 | |
Controls | 8 | 25 | 3 | 15 | 19 | 2 |
Patients | 8 | 25 | 3 | 18 | 16 | 2 |
p = 1.00 | p = 0.77 | |||||
GCA | Grade 0 | Grade 1 | Grade 2 | Grade 0 | Grade 1 | Grade 2 |
Controls | 2 | 32 | 2 | 29 | 7 | 0 |
Patients | 2 | 32 | 2 | 35 | 1 | 0 |
p = 1.00 | p = 0.972 | |||||
Cortical infarcts | 0 | 1 or more | 0 | 1 or more | ||
Controls | 35 | 1 | 36 | 0 | ||
Patients | 34 | 2 | 36 | 0 | ||
p = 0.5 | NA | |||||
Lacunar infarcts | 0 | 1 or more | 0 | 1 or more | ||
Controls | 36 | 0 | 35 | 1 | ||
Patients | 32 | 4 | 35 | 1 | ||
p = 0.057 | p = 0.75 | |||||
Microbleeds | 0 | 1 or more | 0 | 1 or more | ||
Controls | 32 | 4 | 35 | 1 | ||
Patients | 32 | 4 | 34 | 2 | ||
p = 0.65 | p = 0.5 |
Comparisons of white matter changes (Fazeka), global cerebral atrophy (GCA), cortical infarcts, lacunar infarcts, and microbleeds between controls and patients for both reviewers. No significant differences were observed.